Niche focus Target opportunities in long-acting protein therapeutics and radiation exposure treatment applications, leveraging their core capability of less frequent administration with strong efficacy to differentiate in oncology, immunology, and radioprotection markets.

Early stage traction Explore partnerships or grant-backed pilots given their ongoing fundraising history, grant wins, and small revenue base, focusing on co-development, contract research, or milestone-based collaborations to de-risk early-stage programs.

Funding readiness Position as a strategic partner for grant-funded or public-private initiatives, offering technical support, regulatory pathway planning, and manufacturing scale-up expertise to maximize grant impact and accelerate timelines.

Technical fit Leverage existing tech stack and digital presence to engage with the company through targeted outreach on R&D collaborations, contract manufacturing, and data-driven pharmacokinetic/pharmacodynamic studies.

Strategic alignment Highlight synergy with large-cap collaborators in biotechnology and pharma spaces seeking novel long-acting protein platforms, with emphasis on accelerating time-to-benefit and expanding product portfolios.